Home/Filings/4/0001415889-23-002769
4//SEC Filing

Dornan David 4

Accession 0001415889-23-002769

CIK 0001783032other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:26 PM ET

Size

5.5 KB

Accession

0001415889-23-002769

Insider Transaction Report

Form 4
Period: 2023-02-15
Dornan David
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-15+130,000130,000 total
    Exercise: $0.98Exp: 2033-02-14Common Stock (130,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 25% of the total shares on February 15, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

Elevation Oncology, Inc.

CIK 0001783032

Entity typeother

Related Parties

1
  • filerCIK 0001821353

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:26 PM ET
Size
5.5 KB